New president and CEO at Lux Biosciences
This article was originally published in Scrip
Executive Summary
Lux Biosciences (US) has named Dean Mitchell president and chief executive officer. He is the former president, CEO and director of Alpharma. Before joining Alpharma, Mr Mitchell was president and CEO of Guilford Pharmaceuticals, which was acquired by MGI Pharmaceuticals in 2005.
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.